23 Results for "

USP7 selectivity

" in MedChemExpress (MCE) Product Catalog:
Products (23)

23 Results for "USP7 selectivity" in MCE Product Catalog:

Cat. No.: HY-107986R
CAS No.: 2009273-71-4
Research Areas:  

Cancer

GNE-6776 (Standard) is the analytical standard of GNE-6776 (HY-107986). This product is intended for research and analytical applications. GNE-6776 is a selective and orally bioavailable USP7 inhibitor .
loading...
    loading...
Cat. No.: HY-13453R
CAS No.: 19542-67-7
Synonyms: BAY 11-7821 (Standard)
BAY 11-7082 (Standard) is the analytical standard of BAY 11-7082 (HY-13453). This product is intended for research and analytical applications. BAY 11-7082 is an IκBα phosphorylation and NF-κB inhibitor. BAY 11-7082 selectively and irreversibly inhibits the TNF-α-induced phosphorylation of IκB-α, and decreases NF-κB and expression of adhesion molecules. BAY 11-7082 inhibits ubiquitin-specific protease USP7 and USP21 (IC50=0.19, 0.96 μM, respectively). BAY 11-7082 inhibits gasdermin D (GSDMD) pore formation in liposomes and inflammasome-mediated pyroptosis and IL-1β secretion in human and mouse cells .
loading...
    loading...
Cat. No.: HY-179293
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

SARS-CoV-2 PLpro-IN-3 (Compound 15) is a covalent inhibitor of the SARS-CoV-2 papain-like protease (PLpro), with an IC50 of 25 nM. SARS-CoV-2 PLpro-IN-3 has similar inhibitory activity against SARS-CoV PLpro (IC50 = 59 nM), but shows no inhibitory effect on human ubiquitin-specific protease 7 (USP7). The EC50 of SARS-CoV-2 PLpro-IN-3 in inhibiting SARS-CoV-2 replication in cells is 96 nM, significantly reducing the viral titer and viral RNA levels. SARS-CoV-2 PLpro-IN-3 can be used for studying SARS-CoV-2 drug resistance mutations .
loading...
    loading...